And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is, once again, rather modest. We plan to catch up on our reading, promenade with the official mascot, and take a few naps. And what about you? This is a fine time to ready your taxes. You could boost the economy by ordering a delivery from a local restaurant. Or if you have not already done so, you could spend time online searching for a vaccine appointment. Well, whatever you do, have a grand time. But be safe — wear a mask. Enjoy, and see you soon. …

The European Medicines Agency reported that the Covid-19 vaccine produced by AstraZeneca (AZN) was “safe and effective” and did not increase the risk of blood clots, a decision that prompted several major bloc members — including Germany, France, Italy, Spain, Portugal, and the Netherlands — to say they would resume inoculation campaigns, The Wall Street Journal writes. European Union authorities hope the EMA statement will put a problem-plagued vaccination campaign back on track and overcome mistrust of the AstraZeneca shot.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What’s included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.


Leave a Reply

ArabicChinese (Simplified)EnglishFrenchGermanItalianJapanesePortugueseRussianSpanish

[mc4wp_form id="449"]